Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Neuropharmacology|January 5, 2013
Differential anti-ischemic efficacy and therapeutic time window of trans- and cis-hinokiresinols: stereo-specific antioxidant and anti-inflammatory activitiesChung Ju, Sunyoung Hwang, Geum-Sil Cho, et al.
Journal of Medicinal Chemistry|May 2, 2013
Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuseTamara Vasiljevik, Lirit N Franks, Benjamin M Ford, et al.
Cell Biology International|September 4, 2012
Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β2-adrenergic receptors with N-terminal polymorphismsYulia Koryakina, Stacie M Jones, Lawrence E Cornett, et al.
British Journal of Pharmacology|October 1, 2017
The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in miceMolly S Crowe, Catheryn D Wilson, Emma Leishman, et al.
Neuropharmacology|July 10, 2012
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studiesKathryn A Seely, Lisa K Brents, Lirit N Franks, et al.
Anesthesia and Analgesia|May 11, 2017
Evaluation of Analgesia, Tolerance, and the Mechanism of Action of Morphine-6-O-Sulfate Across Multiple Pain Modalities in Sprague-Dawley RatsJai Shankar K Yadlapalli, Navdeep Dogra, Anqi W Walbaum, et al.
Journal of Medicinal Chemistry|April 23, 2021
Synthesis, Molecular Pharmacology, and Structure-Activity Relationships of 3-(Indanoyl)indoles as Selective Cannabinoid Type 2 Receptor AntagonistsHarvey F Fulo, Amal Shoeib, Christian V Cabanlong, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 12, 2019
Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22)Sabrina Jones, Azure L Yarbrough, Amal Shoeib, et al.
Chemical Research in Toxicology|March 13, 2012
A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptorsKathryn A Seely, Lisa K Brents, Anna Radominska-Pandya, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2020
7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligandsNarsimha Reddy Penthala, Amal Shoeib, Soma Shekar Dachavaram, et al.
Pageof 6